Skip to main content
. 2014 Jun 5;25(9):2245–2253. doi: 10.1007/s00198-014-2756-8

Fig. 5.

Fig. 5

Treatment persistence in the Switch and Continue groups. Proportion of persistent patients for each treatment was evaluated at 1, 2, 3, and 6 months of treatment. **p < 0.01, significantly different between groups as analyzed by log-rank test